Mr. Sullivan brings extensive financial leadership experience to Climb. Since joining the Company in 2019 as Vice President, Corporate Controller, Mr. Sullivan has risen internally to his most recent ...
When it comes to the bumper $62bn takeover of UK drugs group Shire by its larger Japanese rival Takeda Pharmaceutical (whose ...